Oncotelic Therapeutics Inc
OTC:OTLC

Watchlist Manager
Oncotelic Therapeutics Inc Logo
Oncotelic Therapeutics Inc
OTC:OTLC
Watchlist
Price: 0.078 USD -8.24% Market Closed
Market Cap: 34.4m USD

Intrinsic Value

OTLC doesn't have a meaningful market cap.

The intrinsic value of one OTLC stock under the Base Case scenario is 0.006 USD. Compared to the current market price of 0.078 USD, Oncotelic Therapeutics Inc is Overvalued by 92%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

OTLC Intrinsic Value
0.006 USD
Overvaluation 92%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Oncotelic Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about OTLC?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is OTLC valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Oncotelic Therapeutics Inc.

Explain Valuation
Compare OTLC to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about OTLC?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Oncotelic Therapeutics Inc

Current Assets 1.6m
Cash & Short-Term Investments 409k
Receivables 4k
Other Current Assets 1.2m
Non-Current Assets 26.5m
Long-Term Investments 22.7m
Intangibles 3.9m
Current Liabilities 20.1m
Accounts Payable 2m
Accrued Liabilities 873.6k
Short-Term Debt 10.3m
Other Current Liabilities 6.8m
Non-Current Liabilities -974.1k
Other Non-Current Liabilities -974.1k
Efficiency

Free Cash Flow Analysis
Oncotelic Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Oncotelic Therapeutics Inc

Revenue
0 USD
Operating Expenses
-689.5k USD
Operating Income
-689.5k USD
Other Expenses
-979.7k USD
Net Income
-1.7m USD
Fundamental Scores

OTLC Profitability Score
Profitability Due Diligence

Oncotelic Therapeutics Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
31/100
Profitability
Score

Oncotelic Therapeutics Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

OTLC Solvency Score
Solvency Due Diligence

Oncotelic Therapeutics Inc's solvency score is 16/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Average D/E
Positive Net Debt
Short-Term Solvency
16/100
Solvency
Score

Oncotelic Therapeutics Inc's solvency score is 16/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OTLC Price Targets Summary
Oncotelic Therapeutics Inc

There are no price targets for OTLC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Oncotelic Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for OTLC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

OTLC Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one OTLC stock?

The intrinsic value of one OTLC stock under the Base Case scenario is 0.006 USD.

Is OTLC stock undervalued or overvalued?

Compared to the current market price of 0.078 USD, Oncotelic Therapeutics Inc is Overvalued by 92%.

Back to Top